Johnson & Johnson Sees FY23 Sales Of $83.6B–$84.0B Compared To Prior Range Of $83.2B–$84.0B And Consensus Of $84.53B
Portfolio Pulse from Benzinga Newsdesk
Johnson & Johnson has updated its FY23 sales forecast to a range of $83.6B-$84.0B, up from the previous range of $83.2B-$84.0B. However, this is still below the consensus estimate of $84.53B.
October 17, 2023 | 10:27 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Johnson & Johnson's updated FY23 sales forecast is slightly higher than its previous estimate but still falls short of the consensus estimate.
While Johnson & Johnson's updated sales forecast is a positive sign, it's still below the consensus estimate. This mixed news is likely to have a neutral impact on the company's stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100